Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Asset Utilization Ratio (2016 - 2025)

Amphastar Pharmaceuticals has reported Asset Utilization Ratio over the past 12 years, most recently at 0.44 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.44 for Q4 2025, down 6.81% from a year ago — trailing twelve months through Dec 2025 was 0.44 (down 6.81% YoY), and the annual figure for FY2025 was 0.45, down 5.22%.
  • Asset Utilization Ratio for Q4 2025 was 0.44 at Amphastar Pharmaceuticals, down from 0.44 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for AMPH hit a ceiling of 0.68 in Q1 2023 and a floor of 0.41 in Q3 2023.
  • Median Asset Utilization Ratio over the past 5 years was 0.49 (2023), compared with a mean of 0.54.
  • Biggest five-year swings in Asset Utilization Ratio: grew 17.73% in 2021 and later plummeted 38.46% in 2023.
  • Amphastar Pharmaceuticals' Asset Utilization Ratio stood at 0.66 in 2021, then increased by 2.69% to 0.68 in 2022, then tumbled by 37.97% to 0.42 in 2023, then grew by 11.22% to 0.47 in 2024, then dropped by 6.81% to 0.44 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.44 (Q4 2025), 0.44 (Q3 2025), and 0.45 (Q2 2025) per Business Quant data.